TransMedics Group, Inc.

Healthcare

NASDAQ:TMDX · NASDAQ Global Market

Market Cap $2.52B Beta 1.88 P/E (TTM) 14.6

$72.91 -0.92%

-$0.68 today

52W Low $60.11High $156.00

Vol 0.66M · Avg 1.31M

EPS (TTM)$5.00

Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-48.97%

Period High

$150.42

Period Low

$62.04

Latest

$72.91

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Bruker Corporation

NASDAQ:BRKR

$8.26B

Glaukos Corporation

NYSE:GKOS

$7.45B

Oscar Health, Inc.

NYSE:OSCR

$7.33B

Kymera Therapeutics, Inc.

NASDAQ:KYMR

$7.09B

Immunovant, Inc.

NASDAQ:IMVT

$6.90B

Hinge Health, Inc.

NYSE:HNGE

$5.06B

Indivior Pharmaceuticals Inc

NASDAQ:INDV

$4.80B

Akero Therapeutics, Inc.

AKRO

$4.50B

NewAmsterdam Pharma Company N.V.

NASDAQ:NAMS

$3.55B

Option Care Health, Inc.

NASDAQ:OPCH

$3.26B

What is the latest TMDX filing?

The latest filing shown is SD dated May 29, 2026.

How many recent filings does TMDX have?

Intrinsic Alpha currently shows 20 recent filings for TMDX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.